A video tour of the top FDA approvals from 2023

The story of how Caribou Biosciences developed a hybrid RNA-DNA guide to increase Cas9 specificity.

Get your pharma heroes nominated by January 12!

Exploring the gaps and opportunities in Canada’s cell and gene workforce.

From flu vaccines, to gene editing, to antibody drug conjugates, and women’s careers; we look back on our 2023 magazine covers.

From renewable energy to bicycle schemes and more; here are just a few examples of how a pharma business can be more sustainable.

How the European Commission has struck deals to secure manufacturing capacity for future emergencies.

Scientists celebrate a new era of genetic medicine but what do we do about the costs?

It’s official: CRISPR medicines are here as UK authorizes exa-cel.

Ongoing issues in the Asian pharma sector prompt an unequivocal response from the FDA and the IPEC Federation.